Group: BD - Becton Dickinson
Catalog excerpts
Antimicrobial Hemostatic IV Dressing GUARD DOWN ACCESS SYSTEMS
Open the catalog to page 1Why settle for a dressing that simply reduces bacteria? The GuardIVa® dressing reduces 99.99% of bacteria† AND controls bleeding‡. As demonstrated through in vitro testing. Data on file. As demonstrated through in vivo testing. Data on file. Simulated testing may not be indicative of actual clincial outcomes.
Open the catalog to page 3The GuardIVa® dressing not only reduces bacteria†, but also controls surface bleeding‡. The GuardIVa® dressing contains Chlorhexidine Gluconate (CHG) sufficient to reduce bacteria by 4 logs (or 99.99%)†, while also allowing healing more consistent with that of untreated wounds‡. What’s more, the GuardIVa® dressing provides hemostasis and antimicrobial protection† in the most critical 24 hours after catheter placement and provides up to 7 days of sustained antimicrobial protection within the dressing. The GuardIVa® dressing is the ONLY antimicrobial dressing indicated to control surface...
Open the catalog to page 4BACTERIAL GROWTH The GuardIVa® dressing was tested against 8 microorganisms commonly associated with catheterrelated bloodstream infections (CRBSI). It has been shown to reduce these bacteria by 4 logs or 99.99%†, and suppress re-growth of microorganisms on the skin‡. In an in vivo test demonstrating the GuardIVa® dressing’s ability to suppress re-growth of skin microflora following skin preparation on healthy human volunteers, the GuardIVa® dressing significantly lowered re-growth of skin microflora at day 7 and day 10 compared to the control‡. The GuardIVa® dressing contains a controlled...
Open the catalog to page 5GuardIVa® dressing Indications for Use: The GuardIVa Antimicrobial Hemostatic IV Dressing is intended for use as a hydrophilic wound dressing to absorb exudate, cover and protect catheter sites. Common applications include IV catheters, other intravenous catheters and percutaneous devices. It is also indicated for control of surface bleeding from percutaneous catheters and vascular access sites. ® Additional Information: The GuardIVa® dressing is not clinically tested for its activity to reduce local infections, catheter related blood stream (CRBSI), and skin colonization of microorganisms...
Open the catalog to page 6All Bard Access Systems catalogs and technical brochures
-
hohn
3 Pages
-
POLY RADPICC® CATHETERS
4 Pages
-
PowerPICC
4 Pages
-
HemoSplit
2 Pages
-
INTRODUCER SETS
1 Pages
-
X-Port? Implantable Port
2 Pages
-
Port Access Kit
2 Pages
-
Bard® Winged Infusion Set
1 Pages
-
Maximal Barrier Kit
2 Pages
-
Site-Scrub® IPA Device
4 Pages
-
Inservice Poster
2 Pages
-
Groshong® Catheters
3 Pages